Search results for "Coronavirus"
COVID-19 spurs hospital tech
Rapid advances have been made in virtual rounds, chatbots, machine learning, and more.
15 Sep 2020
Breakthrough infections, cardiovascular effects of COVID-19, pandemic mental health
Two new studies reported on infections in fully vaccinated people, while another looked at the rate of myocardial infarction and stroke in patients with COVID-19. A survey found depression and anxiety to be common during the pandemic, and the push for mandatory vaccination of health care workers continued.
4 Aug 2021
Psychological, disparate effects of the pandemic detailed by recent research
Mental health problems were prevalent among U.S. adults in June, obesity is strongly associated with mortality from COVID-19, and an inactivated vaccine has shown promise in a phase 1/2 Chinese trial.
19 Aug 2020
Racial disparities in pandemic and society highlighted
A British study highlighted the disproportionate effect of COVID-19 on black pregnant women, and articles by physicians urged action against racism and racial disparities.
17 Jun 2020
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
30 Sep 2020
Good news on IL-6 inhibitors for COVID-19, bad news on other drugs, effects of surge
The NIH updated its guidelines; recent research looked at interleukin-6 (IL-6) inhibitors, ivermectin, remdesivir, and hydroxychloroquine in COVID-19; and one study estimated that 23.2% of inpatient COVID-19 deaths last spring and summer could relate to hospital strain.
14 Jul 2021
ACP Hospitalist provides hospital-based physicians with news and information about the practice of hospital medicine.
New research adds to data on symptoms after COVID-19, vaccines' effects
Several COVID-19 studies looked at persistent symptoms, while new vaccine research found limited antibody responses in some patients and advised on tests for clotting complications. Other studies quantified the target population for tocilizumab treatment and gender differences in infections.
26 May 2021
Mixed results for remdesivir, negative results for canakinumab, and new vaccine information
Remdesivir appeared to be of benefit in one study but was associated with increased length of stay and no improvement in survival in another, an industry-funded trial found no benefit for canakinumab in severe COVID-19, and the FDA noted a possible increased risk for Guillain-Barré syndrome with the Johnson & Johnson (Janssen) vaccine.
21 Jul 2021
Puzzling it out together
Hospitalists share strategies for pandemic problems.
15 Oct 2020